31 Mar 2023
Assets19.39
Total Income19.85
EBITDA2.19
Profit After Tax0.26
NET Worth5.89
Reserves and Surplus2.08
Total Borrowing10.83
At a glance
Updated 2026-08-24The shares listed at ₹59.75, a 38.95% move from the issue price. Goldline Pharmaceutical is a SME IPO with an issue size of ₹11.61 crore, proposed for listing on BSE SME. The offer opens on 12th May 2026 and closes on 14th May 2026. The issue structure includes a fresh issue of ₹11.02 crore. The current listing schedule points to 19th May 2026.
Issue details
Listing atBSE SME
Issue typeBook Build Issue
Issue size₹11.61 Cr
Fresh issue₹11.02 Cr
Face value₹10
Price band₹41.00–₹43.00
Allotment15th May 2026
Listing19th May 2026
Listing performance
Full performance ↗Issue price₹43.00
Listing price₹59.75
Current price—
Listing gain38.95%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹15.00
GMP / upper price34.88%
Est. listing₹58.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens12th May 2026
Closes14th May 2026
Allotment15th May 2026
Refund18th May 2026
Demat18th May 2026
Listing19th May 2026
Subscription demand
Full bidding ↗Total840.74×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 6000 | ₹258,000 |
Company
Use of proceeds
| Object | Amount |
|---|---|
| Prepayment or repayment of all or a portion of certain outstanding borrowings availed by Company | ₹8.35 Cr |
| General Corporate Purposes | ₹1.71 Cr |
| Issue Expense | ₹1.55 Cr |
| Total | ₹11.61 Cr |
Financials
Full financials ↗31 Mar 2024
Assets22.93
Total Income23.57
EBITDA4.30
Profit After Tax1.81
NET Worth7.86
Reserves and Surplus3.76
Total Borrowing11.13
31 Mar 2025
Assets26.28
Total Income28.06
EBITDA5.83
Profit After Tax2.83
NET Worth10.35
Reserves and Surplus1.65
Total Borrowing11.03
31 Dec 2025
Assets27.40
Total Income21.41
EBITDA4.16
Profit After Tax2.22
NET Worth12.36
Reserves and Surplus3.65
Total Borrowing9.47
Trend chart₹ crore
KPIs
| KPI | Mar 31, 2025 | Dec 31, 2025 |
|---|---|---|
| ROE | 35.83% | 21.02% |
| ROCE | 38.45% | 24.22% |
| Debt / Equity | 1.50% | 1.07% |
| RoNW | 27.37% | 17.99% |
| PAT Margin | 10.09% | 10.38% |
| EBITDA Margin | 20.78% | 19.41% |
| Price to Book Value | 3.47 |
Valuation & shareholding
Pre-IPO EPS4.11
Post-IPO EPS3.09
Pre-IPO P/E10.47
Post-IPO P/E13.93
Promoter holding pre79.70%
Promoter holding post57.29%
Market cap₹41.28 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Book Running Lead Manager Fees | ₹0.30 Cr |
| Underwriting Fees | ₹0.55 Cr |
| Market Maker Fees | ₹0.03 Cr |
| Brokerage, selling commission and upload Fees | ₹0.07 Cr |
| Sponsor Bank Fees | ₹0.01 Cr |
| Fees payable to Registrar to Offer | ₹0.02 Cr |
| Fees payable to Legal Advisor | ₹0.05 Cr |
| Statutory Advertisement Expenses | ₹0.06 Cr |
| Fees payable for Marketing & distribution expenses | ₹0.32 Cr |
| Statutory Printing Expenses | ₹0.01 Cr |
| Regulators including stock exchanges Fees | ₹0.07 Cr |
| Fees for Depositories | ₹0.04 Cr |
| Peer Review Auditor Fees | ₹0.03 Cr |
| Total | ₹1.55 Cr |
Registrar & lead managers
Registrar
Bigshare Services Pvt.Ltd.Lead managers
- Cumulative Capital Pvt.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-24.